Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome

被引:65
作者
Barton, Richard C. [1 ]
机构
[1] Leeds Teaching Hosp Trust, Mycol Reference Ctr, Dept Microbiol, Leeds LS1 3EX, W Yorkshire, England
来源
SCIENTIFICA | 2013年 / 2013卷
基金
美国国家卫生研究院;
关键词
D O I
10.1155/2013/459405
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Invasive aspergillosis (IA), an infection caused by fungi in the genus Aspergillus, is seen in patients with immunological deficits, particularly acute leukaemia and stem cell transplantation, and has been associated with high rates of mortality in previous years. Diagnosing IA has long been problematic owing to the inability to culture the main causal agent A. fumigatus from blood. Microscopic examination and culture of respiratory tract specimens have lacked sensitivity, and biopsy tissue for histopathological examination is rarely obtainable.. us, for many years there has been a great interest in nonculture-based techniques such as the detection of galactomannan, beta-D-glucan, and DNA by PCR-based methods. Recent meta-analyses suggest that these approaches have broadly similar performance parameters in terms of sensitivity and specificity to diagnose IA. Improvements have been made in our understanding of the limitations of antigen assays and the standardisation of PCR-based DNA detection.. us, in more recent years, the debate has focussed on how these assays can be incorporated into diagnostic strategies to maximise improvements in outcome whilst limiting unnecessary use of antifungal therapy. Furthermore, there is a current interest in applying these tests to monitor the effectiveness of therapy a. er diagnosis and predict clinical outcomes. The search for improved markers for the early and sensitive diagnosis of IA continues to be a challenge.
引用
收藏
页数:29
相关论文
共 323 条
  • [1] Aceti A, 2008, PEDIATR INFECT DIS J, V27, P769, DOI [10.1097/INF.0b013e31817c0b6e, 10.1097/INF.0b013e31817e840a]
  • [2] A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-β-D-glucan chromogenic assay in serum samples
    Acosta, J.
    Catalan, M.
    del Palacio-Perez-Medel, A.
    Lora, D.
    Montejo, J. -C.
    Cuetara, M. -S.
    Moragues, M. -D.
    Ponton, J.
    del Palacio, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (07) : 1053 - 1060
  • [3] Invasive pulmonary Aspergillosis in patients with chronic obstructive pulmonary disease: An emerging fungal disease
    Ader F.
    [J]. Current Infectious Disease Reports, 2010, 12 (6) : 409 - 416
  • [4] Aspergillus section fumigati:: Antifungal susceptibility patterns and sequence-based identification
    Alcazar-Fuoli, Laura
    Mellado, Emilia
    Alastruey-Izquierdo, Ana
    Cuenca-Estrella, Manuel
    Rodriguez-Tudela, Juan L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1244 - 1251
  • [5] The case for antifungal stewardship
    Ananda-Rajah, Michelle R.
    Slavin, Monica A.
    Thursky, Karin T.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (01) : 107 - 115
  • [6] Detection of Aspergillus galactomannan antigen in foods and antibiotics
    Ansorg, R
    van den Boom, R
    Rath, PM
    [J]. MYCOSES, 1997, 40 (9-10) : 353 - 357
  • [7] The Performance of Real-Time PCR, Galactomannan, and Fungal Culture in the Diagnosis of Invasive Aspergillosis in Ventilated Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Aquino, Valerio R.
    Nagel, Fabiano
    Andreolla, Huander F.
    de-Paris, Fernanda
    Xavier, Melissa O.
    Goldani, Luciano Z.
    Denning, David W.
    Pasqualotto, Alessandro C.
    [J]. MYCOPATHOLOGIA, 2012, 174 (02) : 163 - 169
  • [8] Prospective Monitoring for Invasive Aspergillosis Using Galactomannan and Polymerase Chain Reaction in High Risk Pediatric Patients
    Armenian, Saro H.
    Nash, Kevin A.
    Kapoor, Neena
    Franklin, Janet L.
    Gaynon, Paul S.
    Ross, Lawrence A.
    Hoffman, Jill A.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (12) : 920 - 926
  • [9] Ascioglu S, 2001, MED MYCOL, V39, P35, DOI 10.1080/mmy.39.1.35.40
  • [10] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
    Ascioglu, S
    Rex, JH
    de Pauw, B
    Bennett, JE
    Bille, J
    Crokaert, F
    Denning, DW
    Donnelly, JP
    Edwards, JE
    Erjavec, Z
    Fiere, D
    Lortholary, O
    Maertens, J
    Meis, JF
    Patterson, TF
    Ritter, J
    Selleslag, D
    Shah, PM
    Stevens, DA
    Walsh, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 7 - 14